Status:

COMPLETED

Prospective Clinical Evaluation of Three Prosthesis Re-cap, M2a-Magnum and C2a-taper.

Lead Sponsor:

Frederiksberg University Hospital

Conditions:

Patients Undergoing a THR

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

This evaluation is being conducted to evaluate the performance of thee prosthesis.

Eligibility Criteria

Inclusion

  • Good general health of age (ASA I-II)
  • DEXA-scanning: lower limit for a 55 years old man
  • MRI normal vitality in caput
  • Willing to return for follow-up evaluations

Exclusion

  • Subjects displaying any of the following contra-indications shall be excluded from this evaluation:
  • Inability to co-operate with and complete the study
  • Collum \< 2 cm
  • Large cysts in caput
  • Mismatch between caput acetabulum
  • Caput necrosis

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00284674

Start Date

March 1 2006

Last Update

March 24 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Frederiksberg University Hospital

Copenhagen, Frederiksberg, Denmark, 2000

Prospective Clinical Evaluation of Three Prosthesis Re-cap, M2a-Magnum and C2a-taper. | DecenTrialz